Raja Atreya Selected Research

integrin alpha4beta7

11/2019

Inhibiting PGGT1B Disrupts Function of RHOA, Resulting in T-cell Expression of Integrin α4β7 and Development of Colitis in Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raja Atreya Research Topics

Disease

45	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2022 - 06/2005
45	Crohn Disease (Crohn's Disease) 10/2022 - 04/2003
39	Ulcerative Colitis 12/2022 - 11/2007
29	Inflammation (Inflammations) 01/2022 - 07/2008
23	Colitis 12/2022 - 07/2008
9	Neoplasms (Cancer) 12/2022 - 12/2010
7	Necrosis 05/2022 - 01/2009
6	COVID-19 01/2022 - 01/2020
5	Fibrosis (Cirrhosis) 11/2019 - 01/2010
4	Infections 06/2022 - 11/2019
4	Rheumatoid Arthritis 07/2021 - 11/2007
4	Carcinogenesis 01/2016 - 01/2010
3	Hemorrhage 12/2022 - 04/2019
3	Colonic Neoplasms (Colon Cancer) 09/2012 - 06/2005
2	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 09/2012
2	Abdominal Pain (Pain, Abdominal) 10/2022 - 10/2015
2	Psoriatic Arthritis 07/2021 - 11/2018
2	Pouchitis 01/2021 - 01/2019
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 11/2018 - 12/2010
2	Colitis-Associated Neoplasms 01/2016 - 12/2010
1	Thrombosis (Thrombus) 12/2022
1	Wounds and Injuries (Trauma) 12/2022
1	Thromboinflammation 12/2022
1	Sclerosing Cholangitis 04/2022
1	Microscopic Colitis 01/2022
1	Ileal Diseases 01/2022

Drug/Important Bio-Agent (IBA)

19	CytokinesIBA 02/2022 - 07/2008
15	vedolizumabIBA 11/2022 - 01/2017
12	AntibodiesIBA 01/2022 - 12/2011
11	IntegrinsIBA 11/2022 - 01/2017
9	Interleukin-6 (Interleukin 6)IBA 12/2022 - 06/2005
9	Infliximab (Remicade)FDA Link 06/2022 - 12/2011
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 12/2011
6	InterleukinsIBA 02/2022 - 09/2012
6	Biological ProductsIBA 01/2022 - 03/2014
5	Interleukin-9 (Interleukin 9)IBA 12/2022 - 07/2014
5	OxazoloneIBA 01/2020 - 07/2008
4	Pharmaceutical PreparationsIBA 10/2022 - 02/2019
4	Ustekinumab (CNTO 1275)FDA Link 01/2021 - 02/2019
4	EnzymesIBA 01/2021 - 02/2016
4	Toll-Like Receptor 9IBA 12/2020 - 11/2016
4	Proteins (Proteins, Gene)FDA Link 04/2020 - 01/2014
3	Biosimilar PharmaceuticalsIBA 05/2022 - 08/2019
3	Immunoglobulin G (IgG)IBA 01/2022 - 05/2021
3	tofacitinibIBA 01/2022 - 01/2020
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2021 - 02/2015
3	Immunomodulating AgentsIBA 10/2021 - 05/2021
3	Methotrexate (Mexate)FDA LinkGeneric 10/2021 - 12/2015
3	cobitolimodIBA 12/2020 - 10/2018
3	OligonucleotidesIBA 12/2020 - 02/2017
3	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 11/2016
3	Interleukin-23 (Interleukin 23)IBA 01/2019 - 01/2016
3	Transcription Factors (Transcription Factor)IBA 01/2019 - 07/2008
3	Azathioprine (Imuran)FDA LinkGeneric 12/2015 - 04/2003
2	Arginine (L-Arginine)FDA Link 12/2022 - 11/2020
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 12/2022 - 05/2020
2	Monoclonal AntibodiesIBA 11/2022 - 02/2020
2	C-Reactive ProteinIBA 10/2022 - 01/2021
2	Matrix Metalloproteinases (MMPs)IBA 02/2022 - 01/2010
2	GED0301IBA 01/2022 - 03/2015
2	Antisense OligonucleotidesIBA 01/2022 - 03/2015
2	mRNA VaccinesIBA 10/2021 - 05/2021
2	Immunologic Factors (Immunomodulators)IBA 10/2021 - 05/2021
2	Interleukin-10 (Interleukin 10)IBA 05/2020 - 11/2007
2	SteroidsIBA 01/2020 - 12/2015
2	Collagen Type VIIBA 01/2020 - 01/2019
2	Interleukin-5 (Interleukin 5)IBA 01/2020 - 01/2017
2	Chemokine ReceptorsIBA 01/2020 - 01/2010
2	ChemokinesIBA 01/2020 - 01/2010
2	LigandsIBA 01/2020 - 01/2019
2	Interleukin-13IBA 01/2020 - 01/2017
2	Type II Tumor Necrosis Factor ReceptorsIBA 01/2019 - 01/2017
2	CollagenIBA 01/2019 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 11/2018 - 02/2017
2	DIMS0150IBA 10/2018 - 11/2016
2	CarbohydratesIBA 02/2017 - 01/2016
2	Small Interfering RNA (siRNA)IBA 02/2017 - 01/2016
2	Dextran SulfateIBA 01/2017 - 01/2016
2	Messenger RNA (mRNA)IBA 01/2017 - 01/2016
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2017 - 12/2011
2	Adalimumab (Humira)FDA Link 12/2015 - 12/2011
2	Fluorescein (Funduscein)FDA LinkGeneric 05/2015 - 01/2011
1	Histones (Histone)IBA 12/2022
1	FibrinIBA 12/2022
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 10/2022
1	Sphingosine-1-Phosphate ReceptorsIBA 03/2022
1	ozanimodIBA 03/2022
1	Janus KinasesIBA 03/2022
1	GLPG0634IBA 03/2022
1	Surface Antigens (Surface Antigen)IBA 02/2022
1	Interleukin-2 (IL2)IBA 02/2022
1	Tec protein-tyrosine kinaseIBA 10/2021

Therapy/Procedure

48	Therapeutics 12/2022 - 01/2009
8	Lasers (Laser) 01/2021 - 01/2012
4	Biological Therapy 05/2021 - 01/2009
2	Remission Induction 01/2021 - 02/2020
2	Injections 01/2019 - 01/2017
2	Precision Medicine 11/2016 - 03/2014
2	Colectomy 12/2015 - 08/2015
2	Salvage Therapy 12/2015 - 11/2007